As a pharmaceutical company with many years of experience in manufacturing both single-drug and combination anti-tuberculosis medicines that meet stringent quality standards, Nam Ha Pharma is committed to providing stable, safe, and effective products, contributing to the treatment, control, and prevention of tuberculosis in Vietnam.

On May 7, 2026, Nam Ha Pharma was honored to support the ceremony commemorating the 117th birth anniversary of Dr. Pham Ngoc Thach, the 2025 National Tuberculosis Control Program Review, and the 2026 Program Implementation Plan, organized by the National Lung Hospital in Hanoi.

The 2026 theme, “Tuberculosis Detection Integrated with Periodic Health Check-ups for Every Citizen”, continues to emphasize the importance of proactive screening, early detection, and timely treatment – key factors in the strategy to reduce the burden of tuberculosis.

By maintaining a reliable supply of anti-tuberculosis medicines that meet stringent quality standards, Nam Ha Pharma reaffirms its long-term commitment to supporting the National Tuberculosis Control Program and contributing to the protection of community health.